Treatment of Orthostatic Hypotension in Parkinson's Disease
Begin with non-pharmacological interventions first, then escalate to pharmacological therapy with droxidopa or midodrine as first-line agents, reserving fludrocortisone for refractory cases without supine hypertension. 1
Initial Non-Pharmacological Management
Start all patients with the following conservative measures before considering medications 1:
- Acute water ingestion (≥480 mL) provides temporary relief with peak effect at 30 minutes; avoid adding glucose or salt which reduces the pressor effect 1
- Physical counter-pressure maneuvers including leg crossing, lower body muscle tensing, and squatting (most effective) can acutely increase blood pressure 1
- Compression garments should be at least thigh-high and preferably include the abdomen; shorter garments are ineffective 1
- Increase salt intake to 6-9 grams daily (approximately 1-2 teaspoons) and maintain fluid intake of at least 1500 mL/day 1, 2
- Elevate head of bed 30 degrees when supine to reduce supine hypertension 2
- Review and reduce or eliminate hypotensive medications, diuretics, and antihypertensive agents where safe 1, 2
These non-pharmacological interventions improve gross motor function, balance, and cognitive performance in PD patients with orthostatic hypotension 2.
Pharmacological Treatment Algorithm
First-Line Pharmacological Agents
When non-pharmacological measures are insufficient, choose between:
Droxidopa is particularly beneficial for PD patients specifically 1:
- Improves orthostatic symptoms in Parkinson disease, pure autonomic failure, and multiple system atrophy 1
- Significantly improves standing blood pressure and patient-reported symptom scores 3
- May reduce fall risk 1
- Important caveat: Carbidopa use in PD patients may decrease droxidopa effectiveness 1
- Common side effects: supine hypertension, headache, dizziness, nausea 1
Midodrine as an alternative first-line option 1:
- Dose-dependent improvement in standing blood pressure and symptoms 1
- Side effects: supine hypertension (limiting factor), scalp tingling, piloerection, urinary retention 1
Second-Line Agent
Fludrocortisone should be used only when supine hypertension is absent 1:
- Increases plasma volume and prevents orthostatic hypotension 1
- Critical warning: Use other medications before fludrocortisone when supine hypertension is present 1
- Common side effects: edema, hypokalemia, headache 1
- Serious adverse reactions with doses >0.3 mg daily: adrenal suppression and immunosuppression 1
Clinical Monitoring Considerations
Screening is essential even in asymptomatic patients because orthostatic hypotension can occur at early (premotor) stages of PD and is associated with increased mortality, falls, and cognitive impairment 4, 5, 6:
- Use supine-to-stand blood pressure measurements rather than sit-to-stand testing, as the latter has only 39% sensitivity and substantially underdiagnoses orthostatic hypotension in PD 6
- Measure blood pressure supine and after standing for up to 3 minutes to detect both classical and delayed orthostatic hypotension 7, 8
- Monitor for supine hypertension, which commonly coexists with neurogenic orthostatic hypotension and requires balancing treatment strategies 1, 5
Important Clinical Correlates
Orthostatic hypotension in PD is associated with 6:
- Older age, longer disease duration, lower BMI
- Worse motor and cognitive symptoms
- Overactive bladder symptoms
- Increased fall risk
- Lower fluid intake
Treatment of orthostatic hypotension improves functional outcomes including gross motor function, balance, walking ability, and cognitive performance, making aggressive management worthwhile 2.